Discover how MediPharm Labs is entering Brazil’s growing CBD market, the strict rules it must follow, and what this launch could mean for future expansion.

Canadian cannabis company MediPharm Labs announced the launch of its CBD oral oil in Brazil on November 10, 2026. The product is now available on prescription from pharmacies in Brazil and with local partner Alko do Brasil Indústria e Comércio Ltda.

Manufactured in Canada

The oil is manufactured at MediPharm’s Barrie, Ontario manufacturing facility which is certified under ANVISA (health regulation authority in Brazil) Good Manufacturing Practices. Alko received the Sanitary Authorization with a dossier submitted with help from MediPharm.

“Brazil is one of the fastest-growing medical cannabis markets in the world, but it is also one of the most difficult to access from a regulatory perspective,” said MediPharm CEO Greg Hunter.

Why is Brazil worth it?

The market is large, valued at around C$2.58 billion according to research firm Kaya Mind. Brazil opened up to the market in 2019, only allowing medicinal forms of cannabis such as oils to enter the country. Flower is not permitted.

Strict Regulations on Imported Products

Brazil is very strict with products they import. All batches will have to undergo quality testing within Brazil. The oil can be prescribed by a doctor or dentist but only to those patients that cannot find a suitable treatment from an already approved medication in Brazil. The oil can only be dispensed by a pharmacist and the pharmacy will need to provide the exact medication stated on the prescription.

The label has strict rules. Whilst MediPharm refers to their oil as full spectrum, ANVISA do not allow the use of this word. The packaging must state ‘Canabidiol’ or ‘Extrato de Cannabis sativa’. They must also include the name of the permit holder.

What Now?

The Sanitary Authorization is not a full registration and will only be valid for a certain amount of time. The registry shows Alko’s 100mg/mL drops are authorized until August 2030. Beyond this date the company will need to register as a full medication. This launch is only for this specific product.

As Business Fortune expects if sales are successful there could be more Canadian manufacturers coming into the market with their own partners. However, it remains to be seen if they can get full registration before 2030. Patients and doctors will be keen to see how it goes.

FAQs

Can anyone buy this CBD oil in Brazil?

No. It needs a prescription from a doctor or dentist, and only a pharmacist can dispense it.

Who makes the oil?

MediPharm Labs makes it in Barrie, Ontario. Alko do Brasil holds the Brazilian authorization.

Why can’t the label say “full spectrum”?

ANVISA bans that term, along with “broad spectrum” and “óleo de CBD.” Labels must name the active input and the authorization holder instead.

Is this a full medicine approval?

No. A Sanitary Authorization is a temporary pathway. Continued sales after expiry need medicine registration.

Can Brazilian pharmacies sell cannabis flower?

No. Only pharmaceutical forms such as oils and oral formulations are allowed.

Sources: https://www.mmjdaily.com/article/9891689/medipharm-labs-enters-brazilian-market-with-anvisa-authorized-full-spectrum-cbd-oil/ https://www.securities.io/medipharm-labs-launches-prescription-cbd-oral-oil-in-brazil/